Connect with us
🔹 Hundreds of schools plan closures ahead of red heat alerts 🔹 Watch: Football fans celebrate in Ghana after draw with England 🔹 Sydney woman wakes from induced coma more than a week after shark attack 🔹 Starmer holds talks with Burnham as he seeks 'orderly' transition 🔹 Congress passes war powers measure for first time, rebuking Trump's war with Iran

Uncategorized

Jan Hatzius Team Integrates AI with Innovative Healthcare Initiatives to Lead a New Era of Investing

Published

on

With the rapid advancement of artificial intelligence technology and its widespread application in the financial investment sector, traditional investment models are experiencing a revolutionary leap. Renowned stock analyst Jan Hatzius, together with his elite team of quantitative experts, has developed a cutting-edge AI-powered stock selection system combined with a comprehensive investment education platform. This creates an efficient, innovation-driven, and practice-oriented platform that significantly enhances stock-picking efficiency and investment returns. At the same time, the team actively promotes an innovative healthcare initiative, leveraging the deep integration of AI and the medical industry to open a new frontier that balances technological innovation with wealth growth, helping investors seize vast opportunities in the future health sector.

Jan Hatzius Team Integrates AI with Innovative Healthcare Initiatives to Lead a New Era of Investing

AI-Driven Stock Selection System Boosts Investment Efficiency

Jan Hatzius’ team utilizes massive market data, synthesizing fundamental analysis, technical indicators, and market sentiment across multiple dimensions. By combining machine learning with deep neural network algorithms, they have developed a precise stock screening model. This model can rapidly and dynamically filter stocks with strong growth potential and adequate safety margins while keenly capturing investment opportunities amid market fluctuations—effectively minimizing risks and biases associated with human judgment.

Additionally, the team has developed an AI-driven trade execution module that optimizes timing, helping investors accurately capture short-term buy and sell windows. This enhances trading flexibility and profitability while maintaining strict risk controls, achieving steady portfolio growth and offering members a scientific, systematic, and efficient investing experience.

Comprehensive Education System Fosters Investor Skill Development

Jan Hatzius understands that even the most advanced technical tools can’t unlock their full potential without systematic learning support. To that end, the team has built a multi-dimensional educational platform featuring live online courses, strategy breakdowns, and real-time market data feeds—aimed at helping investors fully grasp the logic and application of AI-driven stock selection.

Members gain systematic mastery of quantitative investment strategies and AI-assisted decision-making techniques, learning to manage portfolios scientifically, adapt quickly to market changes, and enhance risk management skills. By continuously improving their capabilities, members avoid losses caused by emotional decisions and achieve rational, steady wealth growth.

Jan Hatzius Team Integrates AI with Innovative Healthcare Initiatives to Lead a New Era of Investing

Innovative Healthcare Initiative Opens New Investment Opportunities in the Health Sector

Beyond the AI stock selection system, Jan Hatzius’ team is proactively exploring the innovative healthcare field, promoting a fusion of medical technology and artificial intelligence to tap into a promising new investment landscape. Healthcare technology is a key driver for future economic and technological growth, spanning biomedicine, precision medicine, medical devices, and digital health sectors.

Leveraging AI’s powerful data analytics and forecasting capabilities, the team precisely identifies high-quality growth stocks within the healthcare industry, discovering companies with strong innovation potential and commercial viability, and designing scientifically informed investment plans. Through this innovative healthcare initiative, members participate in cutting-edge technology advancements and industry growth while reaping long-term benefits from the booming health economy.

Strong Investment Performance and Growing Member Satisfaction

Since launching the AI stock selection and healthcare initiatives, an increasing number of members have achieved significant investment gains. Data shows that thanks to scientific stock screening and disciplined trade execution, members’ portfolio returns have consistently climbed, with controlled risk levels. Both short-term trades and longer-term positions have performed exceptionally well. Many members report that leveraging AI-based strategies has improved their investment decisions and helped them avoid the pitfalls of herd mentality.

Simultaneously, the team’s robust educational and service offerings have earned widespread praise. Through in-depth coursework and real-time strategy updates, members continually enhance their practical skills, evolving into independent, strategic thinkers capable of flexible execution. Real-time market insights give members the tools to adjust positions promptly, supporting ongoing wealth accumulation and growth.

Future Vision and Member Enrollment Invitation

Positioned at the forefront of AI and big data technologies, Jan Hatzius and his team will continue optimizing AI models and enriching educational content to refine the intelligent investment ecosystem. Going forward, they plan to deepen their investment focus on innovative healthcare, harnessing AI to propel medical technology’s development and create more competitive investment products and services.

Currently, the team is open for membership recruitment, welcoming investors eager to enhance their skills and seize market opportunities. Whether you prioritize nimble short-term trading or seek steady long-term wealth management, Jan Hatzius’ mature AI stock selection system and comprehensive healthcare initiatives provide the technical foundation and strategic guidance needed to confidently navigate financial markets and achieve sustained wealth growth.

Conclusion

As AI technology becomes increasingly prevalent and fintech advances rapidly, Jan Hatzius and his expert team have established a scientifically rigorous, systematically supported wealth-building pathway for investors. Coupled with forward-looking healthcare investments, this approach enables members to tap into the growth dividends within the healthcare sector—delivering both financial and societal value. Pursuing outstanding returns while maintaining controlled risk is the unwavering commitment Jan Hatzius and his team make to every member. They warmly invite more investors to join this new era of intelligent investing intertwined with healthcare innovation, embarking on a shared journey toward wealth expansion and a thriving health industry future.

 

The Press Release Jan Hatzius Team Integrates AI with Innovative Healthcare Initiatives to Lead a New Era of Investing appeared first on Pinion Newswire.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Pharos Network Expands RealFi Alliance with Circle, Avalon Labs, TermMax Finance, Primus & Tulipa Capital to Scale Productive Capital Across Onchain Finance

Hong Kong — June 24, 2026Financial & AI Layer 1 Pharos Network today welcomed Circle, Avalon Labs, TermMax Finance, Primus and Tulipa Capital as the newest strategic partners of the RealFi Alliance led by Pharos Network. This expansion directly tackles one of the most consequential challenges facing onchain finance today, that is expanding productive capital beyond stablecoin yield loops to […]

Published

on

Financial & AI Layer 1 Pharos Network today welcomed Circle, Avalon Labs, TermMax Finance, Primus and Tulipa Capital as the newest strategic partners of the RealFi Alliance led by Pharos Network. This expansion directly tackles one of the most consequential challenges facing onchain finance today, that is expanding productive capital beyond stablecoin yield loops to include the largest pools of onchain liquidity, the deepest asset class in traditional finance, and the trust infrastructure required for institutional scale.

unnamed 4 Pharos Network Expands RealFi Alliance with Circle, Avalon Labs, TermMax Finance, Primus & Tulipa Capital to Scale Productive Capital Across Onchain Finance

Bitcoin, the largest pool of onchain capital, sits largely passive. Fixed income, the deepest asset class in global finance, remains underserved onchain. Institutional capital stays on the sidelines without verifiable trust and compliance frameworks. The industry has the assets, but not yet the productive infrastructure around them.

This cohort is designed when Circle anchors the stack with USDC and CCTP, the regulated settlement layer that moves dollar liquidity natively across chains and into RealFi applications. Avalon Labs activates Bitcoin as working capital, enabling BTC-backed lending, borrowing, and structured yield strategies that connect the largest onchain asset to real-world opportunities. TermMax brings fixed-income and maturity-based products backed by real-world assets onchain, introducing the predictable, institutional-grade yield curve that traditional capital expects. Primus establishes the verification and trust layer through zkTLS and verifiable credentials, enabling compliance-friendly onboarding, reputation systems, and trusted interactions, including for AI agent–driven finance. Tulipa brings institutional capital expertise and professional asset allocation frameworks, channeling sophisticated capital into onchain RealFi opportunities. They extend the RealFi yield layer from stablecoin deposits into a complete productive capital stack covering dollars, Bitcoin, fixed-income, trust, and institutional allocation.

These collaborations among alliance members are already in motion, and deepening. More than 10 alliance members have jointly published an industry perspective report on the state and future of RealFi, setting a shared framework for how onchain finance can move from fragmented tokenization to productive capital at scale. On the product side, R25 Protocol, TopNod, and Ember Protocol (from previous cohorts) are advancing real yield product designs, translating institutional-grade strategies into accessible onchain experiences for users. TermMax is working with Ember Protocol to channel fixed-income strategies into accessible onchain yield products, while Tulipa Capital is leveraging Circle’s USDC for its settlement strategies. These efforts reflect a deliberate shift, that is alliance members are no longer operating as parallel partners, but converging into a tightly coordinated network where research, products, and infrastructure compound on one another. More integrations across alliance members are underway, with additional product launches to come.

“Tokenization without utility is just a database entry.” said Wish Wu, Co-Founder & CEO of Pharos. “What the industry needs now is the productive capital infrastructure around those assets like settlement, Bitcoin liquidity, fixed-income, trust, and institutional allocation working as one stack. That is exactly what this cohort of partners is building together.”

The RealFi Alliance continues to expand as a coalition of the infrastructure providers, asset issuers, and financial applications shaping the future of onchain finance. Previous cohorts include Chainlink, Centrifuge, Faroo, Amber Group, LI.FI Protocol, Vishwa, Agra, Dune Analytics, Anchorage Digital, and others, bringing institutional assets, DeFi players, cross-chain infrastructure, intelligence and data access that established the foundational layer of the RealFi ecosystem. Explore the full RealFi Alliance and the growing list of partners at https://www.pharos.xyz/realfi-alliance.

About Pharos Network

Pharos is a financial and AI Layer 1 built for RealFi. It delivers the compliant infrastructure needed for institutional assets and internet-scale capital markets.

Designed to coordinate real-world financial activity onchain, Pharos combines deep-parallel execution (SALI engine), modular SPNs, and protocol-level compliance infrastructure, integrating ZK-KYC / AML mechanisms, AsyncBFT consensus, native AI agent support (X402 protocol), and dualVM (EVM + WASM compatibility), to support RWAs, stablecoins, cross-border settlement, onchain yield markets, and agent-mediated commerce at internet scale.

The network is supported by strategic partners across the global financial stack, including Circle, Chainlink, Anchorage Digital, Morpho, and Centrifuge, connecting regulated capital markets with onchain liquidity venues where real-world assets can be actively deployed into real-yield-generating strategies.

Built by former Ant Group leadership and engineers, backed by leading global investors across TradFi and crypto, including Sumitomo Corporation, Flow Traders, SNZ, Hack VC, and Faction VC, Pharos is developing the infrastructure layer for the next era of programmable finance and the agentic economy.

Continue Reading

Uncategorized

c8ntinuum Unveils Trust-Minimized Blockchain Interoperability Architecture at WAIB Summit Monaco 2026

MONACO, June 24, 2026The interoperability protocol enters c8ntinuum Summer ahead of a Q4 public release, with over 40,000 verified users joining its SuperApp waitlist in a single week.

Published

on

c8ntinuum, an interoperability protocol building verified cross-chain infrastructure for Web3, has formally unveiled its trust-minimized interoperability architecture at WAIB Summit Monaco 2026. The announcement, made alongside the project’s sponsorship of the VIP Private Dinner at the Yacht Club de Monaco, marks c8ntinuum’s transition from infrastructure development into broader market onboarding and sets the stage for a Q4 2026 public release of its Bridgeless Protocol.

ctm summit cover 1 c8ntinuum Unveils Trust-Minimized Blockchain Interoperability Architecture at WAIB Summit Monaco 2026

The Monaco summit served as the launch platform for c8ntinuum Summer, an integrated program covering B2B interoperability integrations, strategic partnership announcements, SuperApp access, and community expansion through the coming months.

The Bridgeless Architecture

Cross-chain interoperability has long run on bridges, and bridges run on trust. A bridge takes custody on one chain and asks another to believe a message about it, with that belief manufactured by multisigs, oracle networks, and verifier sets. That trust assumption has become the largest attack surface in crypto: CertiK reports more than $328 million in bridge-related losses in 2026 alone.

c8ntinuum’s answer is verification. Through on-chain light clients and ZK light clients, a destination chain checks what happened on a source chain directly, reducing the trust path to the security of the underlying chains and the soundness of the proof system. The proof becomes the authority.

“Recent attacks have made cross-chain security the core pillar around which projects should be built. Our architecture solves the biggest problem in the space: the destination chain should verify the source chain rather than trust a messenger between them.”

— Bogdan Dinulescu, COO, c8ntinuum

The architecture supports three core use cases:

  • General Message Passing — verified cross-chain messages for governance, coordination, state updates and multichain logic
  • Cross-chain swaps — enabling users and applications to access liquidity without navigating fragmented bridge flows
  • Cross-chain smart contract invocations — allowing contracts on one chain to coordinate actions on another, expanding the design space for DeFi, SocialFi, launchpads and automated markets

c8ntinuum Summer

COO Bogdan Dinulescu opened the VIP Private Dinner at the Yacht Club de Monaco, leading two days of conversations with founders, investors, and family offices on cross-chain finance and shared liquidity. Those discussions confirmed a consistent market requirement: cross-chain access without importing an additional trust domain. The summit launched c8ntinuum Summer across four areas:

  • Interoperability and B2B integrations — expanded private testing, additional integration model disclosures, and strategic partner announcements as implementations progress toward the Q4 2026 public release of the Bridgeless Protocol.
  • SuperApp and product access — the c8ntinuum SuperApp is in development as the first public product layer, bringing holding, trading, staking, launching and earning into one interface while abstracting cross-chain routing and verification from the user experience.
  • Market and community expansion — CTM is now available on KuCoin Alpha, Gate Alpha and BitMart. The protocol’s base fee is burned, connecting network usage directly to CTM supply mechanics.
  • Arena seasons — upcoming performance-based Arena seasons will evaluate projects and communities through transparent on-chain indicators, holder growth, trading volume, and user activity, connecting ecosystem opportunities to measurable performance.

The program launched with strong early momentum: 40,000 verified users joined the SuperApp waitlist in a single week, and 5,000 OG community roles were claimed in under 24 hours.

Bogdan Dinulescu panel 1 c8ntinuum Unveils Trust-Minimized Blockchain Interoperability Architecture at WAIB Summit Monaco 2026

The Road to Q4

The Bridgeless Protocol targets a public release in Q4 2026. Between now and then, c8ntinuum will advance private SDK integrations into named partner work and move the SuperApp toward launch as the first public-facing product. The waitlist remains the last point of entry without a referral code: app.c8ntinuum.com.

About c8ntinuum

c8ntinuum is a universal interoperability protocol and forward-compatible EVM chain built around trust-minimized cross-chain verification. The protocol verifies source-chain activity through light clients and ZK light clients, reducing reliance on privileged third parties such as multisigs, TSS or MPC groups, oracle networks or operator committees. c8ntinuum is building infrastructure for general message passing, cross-chain swaps, cross-chain smart contract invocations and shared liquidity across Web3, with a product ecosystem that includes the c8ntinuum chain, a SuperApp and private interoperability SDK integrations. The network is secured by a validator set that includes Dokia Capital, one of the biggest and oldest institutional staking providers and the only licensed validator in the Principality of Monaco.

www.c8ntinuum.com   |   docs.c8ntinuum.com

X @c8ntinuum   |   Telegram @c8ntinuum   |   Discord discord.gg/c8ntinuum

Media Contact
Mihai Pop, Marketing Manager — [email protected]

c8ntinuum

Continue Reading

Uncategorized

SUIC and VisionRenu Biomedical Sign Strategic Agreement to Explore Merger, Investments, U.S. Capital Market Cooperation

NEW YORK, NYSUIC Worldwide Holdings Ltd. (OTC Markets: SUIC) (“SUIC”) and VisionRenu Biomedical Technology Co., Ltd. (“VisionRenu”), a Taiwan-based medical technology company specializing in brain health and ophthalmic medical devices, today announced the signing of a Strategic Merger & U.S. Capital Market Cooperation Framework Agreement (MOU). The framework agreement establishes a long-term strategic partnership to explore collaboration […]

Published

on

SUIC Worldwide Holdings Ltd. (OTC Markets: SUIC) (“SUIC”) and VisionRenu Biomedical Technology Co., Ltd. (“VisionRenu”), a Taiwan-based medical technology company specializing in brain health and ophthalmic medical devices, today announced the signing of a Strategic Merger & U.S. Capital Market Cooperation Framework Agreement (MOU).

uic SUIC and VisionRenu Biomedical Sign Strategic Agreement to Explore Merger, Investments, U.S. Capital Market Cooperation

The framework agreement establishes a long-term strategic partnership to explore collaboration in medical technology, brain health, vision care, healthcare innovation, international financing, and U.S. capital market development.

Under the MOU, the parties intend to evaluate a broad range of strategic opportunities, including:

  • Strategic investments;
  • Mergers and acquisitions;
  • Share exchange transactions
  • Business combinations;
  • International financing initiatives;
  • Product commercialization; and
  • U.S. capital market development and expansion.

 

VisionRenu is the developer of the MagRenu® Transcranial Magnetic Stimulation (TMS) System, a non-invasive, drug-free medical device approved by Taiwan’s Food and Drug Administration (TFDA) for the treatment of depression. The company is also advancing a proprietary ophthalmic technology platform, including an innovative presbyopia laser system designed for international markets.

Through this strategic collaboration, SUIC and VisionRenu expect to leverage their complementary strengths in medical technology innovation, commercialization, international business development, and access to global capital markets. The parties believe the collaboration may accelerate VisionRenu’s international expansion while creating long-term value through strategic financing and potential capital market initiatives in the United States.

Management from both companies expressed confidence that the framework agreement represents an important first step toward building a comprehensive strategic alliance. The parties will continue conducting due diligence and evaluating various transaction structures that may include strategic investment, merger, acquisition, or other forms of business combination, subject to further negotiations, definitive agreements, corporate approvals, and applicable regulatory requirements.

This Framework Agreement is non-binding, except for customary provisions relating to confidentiality and good-faith cooperation, and does not obligate either party to complete any specific transaction.

About VisionRenu Biomedical Technology Co., Ltd.

VisionRenu Biomedical Technology Co., Ltd. is a Taiwan-based medical technology company focused on the research, development, manufacturing, and commercialization of innovative medical devices for brain health and ophthalmic care. Its flagship product, the MagRenu® Transcranial Magnetic Stimulation (TMS) System, is approved by Taiwan’s TFDA for the treatment of depression. The company is also developing proprietary ophthalmic laser technologies designed to address the growing global demand for advanced vision care solutions. To learn more about the company, please visit https://www.vision-renu.com/

About SUIC Worldwide Holdings Ltd.

SUIC Worldwide Holdings Ltd. (OTC Markets: SUIC) is a technology-enabled investment and business acceleration company focused on acquiring and developing innovative businesses with high-growth potential. Through strategic investments, mergers and acquisitions, and access to international capital markets, SUIC supports portfolio companies in expanding globally and creating long-term shareholder value. Please visit our website, https://sinounitedco.com/

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. These statements are based on current expectations regarding future events and are subject to various factors that could cause actual results to differ materially from those expressed or implied. The Framework Agreement announced herein is non-binding, and there can be no assurance that any definitive transaction will be completed. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.

Media Contact

SUIC Worldwide Holdings Ltd.

News Release Department (929) 391-2550.

Name

Jenny Kan

Email Address

[email protected]

Continue Reading

Trending